antiproliferative agents (Jiangxi Science & Technology Normal University/Shenyang Pharmaceutical University/Harbin Medical University)

N/A

Report date: 2025/03/14 16:29:31
NME

Base Information

Drug Nameantiproliferative agents (Jiangxi Science & Technology Normal University/Shenyang Pharmaceutical University/Harbin Medical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsHepatocyte growth factor receptor inhibitors
TargetsTyrosine-protein kinase receptor FLT3Hepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangxi Science & Technology Normal University
China Registration ClassN/A

Develop Information

Active CompaniesJiangxi Science & Technology Normal UniversityHarbin Medical UniversityShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A